CLINICAL TRIALS PROFILE FOR CAVERJECT
✉ Email this page to a colleague
All Clinical Trials for CAVERJECT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00544076 ↗ | ED Recovery in Men Age =65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer | Terminated | City of Hope Medical Center | Phase 3 | 2006-01-01 | RATIONALE: Sildenafil citrate and alprostadil may help patients who have undergone prostatectomy for prostate cancer to recover from erectile dysfunction. PURPOSE: This randomized clinical trial is studying giving sildenafil together with alprostadil in treating patients undergoing nerve-sparing robotic-assisted radical prostatectomy for nonmetastatic prostate cancer. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CAVERJECT
Condition Name
Clinical Trial Locations for CAVERJECT
Trials by Country
Clinical Trial Progress for CAVERJECT
Clinical Trial Phase
Clinical Trial Sponsors for CAVERJECT
Sponsor Name